2013
DOI: 10.1016/s1569-9056(13)62391-x
|View full text |Cite
|
Sign up to set email alerts
|

P066 Results of surgical treatment of localized and locally-advanced prostate cancer patients in subject to volume of lymph node dissection performed

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2017
2017
2019
2019

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…Similarly, ePLND did not alter BCR rates at a median follow-up of 36 months in a retrospective study by Kim et al [40]. Furthermore, ePLND did not provide better biochemical outcome in four comparative studies [39,41,42]. However, all these studies were retrospective in design, and three of them were conference abstracts.…”
Section: Biochemical Recurrencementioning
confidence: 93%
See 1 more Smart Citation
“…Similarly, ePLND did not alter BCR rates at a median follow-up of 36 months in a retrospective study by Kim et al [40]. Furthermore, ePLND did not provide better biochemical outcome in four comparative studies [39,41,42]. However, all these studies were retrospective in design, and three of them were conference abstracts.…”
Section: Biochemical Recurrencementioning
confidence: 93%
“…Cancer-specific mortality was reported in one conference abstract [41] that showed that ePLND did not provide a statistically significant survival benefit over sPLND (p>0.05). However, the median follow-up was 34 months, presumably too short for addressing survival outcomes of prostate cancer.…”
Section: Cancer-specific and Overall Mortalitymentioning
confidence: 99%
“…A recent systematic review and meta-analysis involving seven studies demonstrated that ePLND could provide oncological benefit for biochemical recurrence-free survival compared to sPLND 18 . Nevertheless, Nyushko and colleagues analyzed long-term outcomes of patients with localized PCa and reported no significant difference in CSS and OS between patients with ePLND and sPLND 19 . When compared to patients who did not receive PLND, no consensus has been reached to support the use of ePLND in terms of survival outcomes.…”
Section: Discussionmentioning
confidence: 99%